These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15735189)

  • 1. Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training.
    Lee S; Hudson R; Kilpatrick K; Graham TE; Ross R
    Diabetes Care; 2005 Mar; 28(3):566-72. PubMed ID: 15735189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss.
    Petrie HJ; Chown SE; Belfie LM; Duncan AM; McLaren DH; Conquer JA; Graham TE
    Am J Clin Nutr; 2004 Jul; 80(1):22-8. PubMed ID: 15213023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men.
    Gan SK; Kriketos AD; Ellis BA; Thompson CH; Kraegen EW; Chisholm DJ
    Diabetes Care; 2003 Jun; 26(6):1706-13. PubMed ID: 12766098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans.
    Greer F; Hudson R; Ross R; Graham T
    Diabetes; 2001 Oct; 50(10):2349-54. PubMed ID: 11574419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pinitol treatment on insulin action in subjects with insulin resistance.
    Davis A; Christiansen M; Horowitz JF; Klein S; Hellerstein MK; Ostlund RE
    Diabetes Care; 2000 Jul; 23(7):1000-5. PubMed ID: 10895854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes.
    Robinson LE; Savani S; Battram DS; McLaren DH; Sathasivam P; Graham TE
    J Nutr; 2004 Oct; 134(10):2528-33. PubMed ID: 15465742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes.
    O'Gorman DJ; Karlsson HK; McQuaid S; Yousif O; Rahman Y; Gasparro D; Glund S; Chibalin AV; Zierath JR; Nolan JJ
    Diabetologia; 2006 Dec; 49(12):2983-92. PubMed ID: 17019595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men.
    Rice B; Janssen I; Hudson R; Ross R
    Diabetes Care; 1999 May; 22(5):684-91. PubMed ID: 10332666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caffeine-induced impairment of insulin action but not insulin signaling in human skeletal muscle is reduced by exercise.
    Thong FS; Derave W; Kiens B; Graham TE; Ursø B; Wojtaszewski JF; Hansen BF; Richter EA
    Diabetes; 2002 Mar; 51(3):583-90. PubMed ID: 11872654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of exercise training on insulin sensitivity and glucose metabolism in lean, obese, and diabetic men.
    Segal KR; Edano A; Abalos A; Albu J; Blando L; Tomas MB; Pi-Sunyer FX
    J Appl Physiol (1985); 1991 Dec; 71(6):2402-11. PubMed ID: 1778939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis.
    Basu R; Chandramouli V; Dicke B; Landau B; Rizza R
    Diabetes; 2005 Jul; 54(7):1942-8. PubMed ID: 15983193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with Type 2 diabetes.
    Bruce CR; Kriketos AD; Cooney GJ; Hawley JA
    Diabetologia; 2004 Jan; 47(1):23-30. PubMed ID: 14673522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A heterogeneous response of liver and skeletal muscle fat to the combination of a Paleolithic diet and exercise in obese individuals with type 2 diabetes: a randomised controlled trial.
    Otten J; Stomby A; Waling M; Isaksson A; Söderström I; Ryberg M; Svensson M; Hauksson J; Olsson T
    Diabetologia; 2018 Jul; 61(7):1548-1559. PubMed ID: 29696296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity.
    Yamanouchi K; Shinozaki T; Chikada K; Nishikawa T; Ito K; Shimizu S; Ozawa N; Suzuki Y; Maeno H; Kato K
    Diabetes Care; 1995 Jun; 18(6):775-8. PubMed ID: 7555502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone improves exercise capacity in individuals with type 2 diabetes.
    Regensteiner JG; Bauer TA; Reusch JE
    Diabetes Care; 2005 Dec; 28(12):2877-83. PubMed ID: 16306548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys.
    Hotta K; Funahashi T; Bodkin NL; Ortmeyer HK; Arita Y; Hansen BC; Matsuzawa Y
    Diabetes; 2001 May; 50(5):1126-33. PubMed ID: 11334417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelin-1 levels increase during euglycemic hyperinsulinemic clamp in lean NIDDM men.
    Ferri C; Carlomagno A; Coassin S; Baldoncini R; Cassone Faldetta MR; Laurenti O; Properzi G; Santucci A; De Mattia G
    Diabetes Care; 1995 Feb; 18(2):226-33. PubMed ID: 7729302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.